Your search returned 2 results.

Results
	1.	Bone marrow cellularity at day 14 is the most important predictive factor for response in patients with AML who require double-induction chemotherapy: Analysis from a large, single institution experience. [electronic resource] by Griffin, Patrick T Komrokji, Rami S Sweet, Kendra Al Ali, Najla H Padron, Eric Kubal, Timothy E List, Alan F Lancet, Jeffrey E Producer: 20170717 In: American journal of hematology vol. 92 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Prospective CYP2C19-Guided Voriconazole Prophylaxis in Patients With Neutropenic Acute Myeloid Leukemia Reduces the Incidence of Subtherapeutic Antifungal Plasma Concentrations. [electronic resource] by Hicks, J Kevin Quilitz, Rod E Komrokji, Rami S Kubal, Timothy E Lancet, Jeffrey E Pasikhova, Yanina Qin, Dahui So, Wonhee Caceres, Gisela Kelly, Kerry Salchert, Yasmina S Shahbazian, Kevin Abbas-Aghababazadeh, Farnoosh Fridley, Brooke L Velez, Ana P McLeod, Howard L Greene, John N Producer: 20201028 In: Clinical pharmacology and therapeutics vol. 107 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

Refine your search